Resultados de la búsqueda 721-730 of 5827 for Phase

  1. Obstetricia y Ginecología - Ensayos clínicos

    Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with critozinib ...

  3. Ensayos clínicos - Neurología

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

  5. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

  6. Ensayos clínicos - Neurología

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  7. Ensayos clínicos - Neurología

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  8. Ensayos clínicos - Neurología

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  9. Ensayos clínicos - Neurología

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...